We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00207168
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : April 22, 2011
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Dohme Australia
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2006
  Study Completion Date : December 2006
  Certification or Request for Extension to Delay Results Submission: February 3, 2010